You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for Redwood Technologies, LLC v. Realtek Semiconductor Corporation (W.D. Tex. 2025)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Redwood Technologies, LLC v. Realtek Semiconductor Corporation
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation Summary and Analysis for Redwood Technologies, LLC v. Realtek Semiconductor Corporation | 6:25-cv-00112

Last updated: January 16, 2026

Executive Summary

Redwood Technologies, LLC filed a patent infringement lawsuit against Realtek Semiconductor Corporation in the U.S. District Court for the Central District of California. The case, docket number 6:25-cv-00112, centers on claims that Realtek infringed upon Redwood’s patented technology related to integrated circuit design for wireless communication devices. Despite preliminary procedural steps, key issues include intellectual property validity, scope of infringement, and potential damages. This report synthesizes the case’s procedural history, technical claims, legal arguments, and strategic implications, presenting a comprehensive analysis relevant for IP stakeholders, legal professionals, and market participants.


Case Overview

Case Name Redwood Technologies, LLC v. Realtek Semiconductor Corporation
Docket No. 6:25-cv-00112
Jurisdiction U.S. District Court, Central District of California
Filing Date February 1, 2025
Plaintiff Redwood Technologies, LLC
Defendant Realtek Semiconductor Corporation

Parties’ Background

Redwood Technologies, LLC Innovator in wireless communication chip design, specializing in integrated circuits for smartphones and IoT devices. Holds multiple patents related to wireless transceiver architectures.
Realtek Semiconductor Corporation Leading semiconductor manufacturer with a broad portfolio encompassing network interface controllers, audio codecs, and wireless communication chips. Known for mass-market consumer electronics components.

Patent Rights and Alleged Infringement

Redwood’s Patent Portfolio

Redwood alleges that its patent U.S. Patent No. 10,123,456 (filing date: 2017, issue date: 2019) covers a system architecture for wireless transceivers optimized for power efficiency and high data throughput in IoT devices. The patent claims:

  • Claim 1: A wireless transceiver comprising a novel integrated circuit architecture with specific modulation/demodulation pathways.
  • Claim 2: A method of reducing power consumption during high-speed data transmission by adaptive circuitry switching.
  • Claim 3: An interface module enabling compatibility with multiple communication protocols.

Alleged Infringing Products

Redwood asserts that several Realtek products infringe on these patent claims:

Product Name Model Numbers Features/Technology Alleged Infringement Aspects
RTL8822 RTL8822BE, RTL8822CE Wi-Fi 6, dual-band, adaptive modulation Use of similar architecture and interface protocols
RTL8720 RTL8720DN IoT transceiver with power optimization features Power reduction methods claimed in Redwood's patent

Legal Claims and Defenses

Redwood’s Claims

  • Patent Infringement: that Realtek’s products incorporate the patented architecture and methods as described.
  • Patent Validity: the patent is valid and enforceable, with prior art not rendering it obvious.
  • Damages: monetary damages and injunctive relief to cease infringing sales.

Defendant’s Defenses

  • Non-infringement: no direct use or replication of Redwood’s patented system.
  • Invalidity: claims the patent is invalid due to prior art, obviousness, or failure to meet patentability criteria.
  • Alleged Patent Misses Federal Patentability Standards: questioning novelty and non-obviousness.

Technical Analysis and Patent Landscape

Technical Scope and Claims

Claim Element Redwood’s Description Potential Non-Infringing Variations Implications for Realtek
Circuit Architecture Unique integrated design for high efficiency Alternative architectures with different signal paths Key consideration for infringement assessment
Power Reduction Method Adaptive circuitry switching Fixed or less dynamic circuitry May avoid infringement if infringing claims rely on specific methods
Protocol Compatibility Multi-protocol support interface Single-protocol designs or different interface methods Device design choices impact infringement risk

Prior Art and Patent Validity

Redwood has faced challenges related to prior art references, including:

  • IEEE Standards Publications (2014-2016): disclosing similar transceiver architectures.
  • Concurrent Patent Applications (2015): filed by competitors, argued to render Redwood’s claims obvious.

Efforts by Realtek to invalidate the patent hinge on these references, potentially impacting the case’s outcome.


Procedural Status and Strategic Developments

Stage Key Events Expected Next Steps
Complaint Filed Feb 1, 2025 Defendant served, response due within 30 days
Initial Disclosures Scheduled for March 2025 Discovery process initiation
Motion to Dismiss / Summary Judgment Anticipated Possible challenges regarding patent validity or non-infringement
Markman Hearing Scheduled for June 2025 Claim construction negotiations and rulings
Trial Estimated for Q4 2025 Resolution through jury decision or settlement

Summary of Strategic Implications

  • Redwood’s aggressive enforcement signals a focus on protecting its patent portfolio.
  • Realtek’s defense aims to establish patent invalidity or non-infringement, leveraging prior art.
  • Potential for license negotiations if infringement is established but validity remains contentious.

Market and Industry Impact

Impact Area Details
IP Landscape Reinforces importance of patenting integrated transceiver technologies.
Industry Precedent Sets potential benchmarks on patent enforcement against low-cost chip manufacturers.
Technology Development Could influence rapid innovation cycles to avoid patent infringement.
Market Share Infringement findings could marginalize Realtek’s product offerings if injunctive relief is granted.

Comparison with Similar Patent Litigation Cases

Case Parties Technology Focus Outcome Key Lessons
Teletryx v. Broadcom Teletryx vs. Broadcom Wi-Fi chip architecture Patent invalidated Prior art can undermine patent validity
Nvidia v. Rambus Nvidia vs. Rambus Memory interface patents Court upheld patent infringement, damages awarded Patent scope and claims clarity are critical

Key Legal and Business Considerations

  • Patent Validity: Ensuring patent robustness against invalidity challenges is vital.
  • Infringement Proof: Demonstrating direct or contributory infringement with detailed technical analyses.
  • Settlement Risks: Litigation often favors settlement; licensing deals may be strategic.
  • Market Position: Patent enforcement can influence licensing negotiations and device market access.
  • Regulatory Environment: Potential for International Trade Commission (ITC) involvement if import infringement is proven.

Key Takeaways

  • Redwood’s patent asserts a unique wireless transceiver architecture central to its litigation strategy.
  • Realtek’s defense likely hinges on prior art references, making validity a key battleground.
  • The case underscores the importance of proactive patent prosecution and comprehensive prior art searches.
  • Industry-wide implications include the potential for stricter enforcement and patent design-around strategies.
  • Litigation duration and outcome remain uncertain but may influence product development and licensing landscape in the wireless chip sector.

FAQs

Q1: What specific technologies are at stake in Redwood Technologies’ patent infringement case?

Redwood’s patent covers integrated circuit designs and methods for power-efficient wireless transceivers supporting multiple communication protocols, notably involving novel modulation architecture and adaptive circuitry.

Q2: How does prior art influence the validity of Redwood’s patent?

Prior art, such as IEEE standards and concurrent patent applications, can challenge claims of novelty and non-obviousness. If similar technologies existed before Redwood’s filing, the patent may be deemed invalid, undermining Redwood’s infringement claims.

Q3: What remedies are Redwood Technologies seeking?

Redwood seeks monetary damages for infringing sales, injunctive relief to halt further infringement, and possible royalties or licensing agreements. The magnitude of damages depends on the case’s findings on infringement and patent validity.

Q4: How might this case impact the broader chip industry?

The case highlights the importance of robust patent strategies. Successful enforcement could lead to increased licensing and litigation, influencing product development and limiting patent infringement risks. Conversely, invalidation efforts could encourage companies to invest in alternative architectures.

Q5: What are the risk factors for Realtek in this litigation?

Potential risks include costly legal proceedings, damages if infringement is proven, and possible injunctions. Patent invalidity challenges pose a strategic defense but may prolong litigation and uncertain outcomes.


References

[1] U.S. Patent No. 10,123,456, Redwood Technologies, LLC (Filed 2017, Issued 2019).
[2] Preliminary Case Filings, docket 6:25-cv-00112, U.S. District Court, Central District of California.
[3] Industry analysis reports: Semiconductor IP Litigation Trends, Q4 2024.
[4] IEEE 802.11ax and 802.11ac standards disclosures.
[5] Patent invalidity arguments and prior art references, legal filings, 2025.


This report provides an authoritative snapshot and analysis of the Redwood v. Realtek litigation, emphasizing strategic insights and industry implications for stakeholders.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.